Abcam, ab258502, Human LRWD1 knockout HeLa cell lysate

Size: 1Kit
LRWD1 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and Insertion of the selection cassette in exon1.
Key facts
Cell type:HeLa,
Species or organism:Human,
Tissue:Cervix,
Knockout validation:Sanger Sequencing,
Mutation description:Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and Insertion of the selection cassette in exon1.,
Disease:Adenocarcinoma

Product details:
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation:
Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10).
This means that the protein of interest is denatured.
If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions:
Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our
limited use license
patent pages

Properties and Storage Information:
Gene name-LRWD1, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Sanger Sequencing, Shipped at conditions-Ambient - Can Ship with Ice, Appropriate short-term storage conditions--20°C, Appropriate long-term storage conditions--20°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
The LRWD1 also known as Leucine-rich repeats and WD repeat-containing protein 1 plays an essential mechanical role in cells. This protein weighs approximately 63 kDa and is expressed mainly in tissues such as the testis. LRWD1 has structural domains that include leucine-rich repeats and WD repeat domains contributing to its role in protein interactions and signaling pathways.
Biological function summary
LRWD1 supports the regulation of DNA replication and centrosome cycle. It is an integral part of the DNA replication licensing pathway ensuring proper DNA synthesis during the cell cycle. By participating in this complex LRWD1 collaborates with proteins like CDC6 and CDT1 to initiate DNA replication. This protein ensures that cells duplicate their DNA once per cycle maintaining genomic stability.
Pathways
LRWD1 participates in the DNA replication pathway and is also linked to the G2 to M phase transition of the cell cycle. Through the DNA replication pathway LRWD1 works hand-in-hand with other factors such as ORC1 and MCM proteins which coordinate the licensing of replication origins. Its presence in these pathways demonstrates its pivotal role in maintaining normal cell cycle progression and genomic integrity.
LRWD1 has associations with disorders involving improper DNA replication and genome instability. Misregulation of this protein can relate to conditions such as cancer due to its involvement in cell cycle control. In cancer LRWD1's interaction with DNA replication-related proteins highlights the pathway's relevance in tumorigenesis. Researchers continue to investigate its role and potential connections to proteins like p53 which is frequently mutated in cancers.